In Clinical pharmacological trials the determination of the optimum regimen for a drug using the technique of response surface analysis is proposed as being more advantageous than traditional analyses of dose response relationships. Major considerations in favour of this technique are that the optimum regimen can be identified with a minimum of human experimentation, and unacceptable regimens are eliminated from the study early, at a substantial saving of time and money.
Get full access to this article
View all access options for this article.
References
1.
BoxG EP (1954) The exploration and exploitation of response surfaces: Some general considerations and examples. Biometrics10, 16
2.
BrossI DJ (1958) Sequential clinical trials. Journal of Chronic Diseases8, 349
3.
HochmanE HLangmanM KDesjardinsR (1972) Drug evaluation by statistical analysis of clinical trials. Proceedings of San Diego Biomedical Symposium (February)
4.
MeadRPikeD J (1975) A review of response surface methodology from a biometric viewpoint. Biometrics31, 803
5.
MyersR H (1971) Response Surface Methodology. Allyn and Bacon Inc, Boston
6.
WaldA (1947) Sequential Analysis. John Wiley & Sons, New York
